Pfizer announced Thursday that a third shot of its COVID-19 vaccine raised omicron-fighting antibody by 36 times in children ages 5 to 11. Pfizer/BioNTech plans to request emergency use authorization ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...

The group will discus and vote on whether to recommend Pfizer booster shots. The Food and Drug Administration's independent advisory committee will convene in open session Friday to review the latest ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (Nexstar) — A U.S. Food and Drug ...

A key advisory panel to the Centers for Disease Control and Prevention (CDC) voted Thursday to endorse the administration of Pfizer’s COVID-19 booster shots to those 65 and older, nursing home ...

The Food and Drug Administration will likely authorize Pfizer's COVID-19 booster shot for adolescents aged 12 to 15 by next week, The Washington Post and The New York Times reported on Thursday. The ...